MSB 7.69% $1.19 mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-25

  1. 41 Posts.
    lightbulb Created with Sketch. 7
    Possibly the best announcement long term shareholders have received. Only a matter of time now, congrats MSB.

    And thank you to the FDA for their "collaborative approach."
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.